Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-02

FDA Approved: ALCAFTADINE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved the original application for ALCAFTADINE (alcaftadine) by Alembic Pharmaceuticals as a generic ophthalmic solution for allergy-related conjunctivit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALCAFTADINE (ALCAFTADINE)

Snippet

ORIG AP for ALCAFTADINE (ALCAFTADINE)